发明名称 Enhanced drug delivery in transdermal systems
摘要 A composition for transdermal administration resulting from an admixture includes: a therapeutically effective amount of a drug that includes a parent drug and a prodrug; and a pharmaceutically acceptable carrier, wherein the parent drug and prodrug are individually present in an amount sufficient for a pharmacological effect. In a preferred embodiment, the admixture includes: a therapeutically effective amount of a pharmaceutically active agent that includes a corresponding steroid and a steroid derivative; and a carrier for the pharmaceutically active agent. The steroid and the corresponding steroid derivative are present in a weight ratio of 10:1 to 1:10 steroid: corresponding steroid derivative. In a preferred embodiment ratio is 6:1 to 1:6. In a preferred embodiment, the corresponding steroid derivative is a steroid ester. In another preferred embodiment, the carrier is a polymer that includes a pressure-sensitive adhesive. In another preferred embodiment, the parent drug is an ACE inhibitor such as ramipril and the prodrug is an ACE inhibitor prodrug such as ramipril ethyl and/or methyl ester.
申请公布号 US2008167365(A1) 申请公布日期 2008.07.10
申请号 US20070979227 申请日期 2007.10.31
申请人 NOVEN PHARMACEUTICALS, INC. 发明人 HOUZE DAVID;NGUYEN VIET
分类号 A61K31/403;A61K9/00;A61K9/70;A61K31/56;A61K31/565;A61K31/567;A61K31/5685;A61K31/57;A61K31/573;A61K38/55;A61K45/00;A61K45/06;A61K47/10;A61K47/12;A61K47/32;A61K47/34;A61K47/48;A61P5/26;A61P5/30;A61P9/12;A61P43/00 主分类号 A61K31/403
代理机构 代理人
主权项
地址